Race Oncology Limited (RAC.AX)
AUD 1.18
(-2.89%)
AUD 1.18
(-2.89%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -14.2 Million AUD | -11.17% |
| 2023 | -12.77 Million AUD | -13.4% |
| 2022 | -11.62 Million AUD | -80.87% |
| 2021 | -6.44 Million AUD | -68.38% |
| 2020 | -3.72 Million AUD | -5.67% |
| 2019 | -3.6 Million AUD | 42.71% |
| 2018 | -6.22 Million AUD | -60.28% |
| 2017 | -3.93 Million AUD | -664.24% |
| 2016 | - AUD | -14470.11% |
| 2015 | 3454.00 AUD | 21.54% |
| 2014 | 2844.00 AUD | -4.47% |
| 2013 | -40.14 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -9.47 Million AUD | 0.0% |
| 2024 Q4 | -8.27 Million AUD | 0.0% |
| 2024 FY | - AUD | -38.13% |
| 2023 Q2 | -5.42 Million AUD | 0.0% |
| 2023 FY | - AUD | -13.4% |
| 2023 Q4 | -7.27 Million AUD | 0.0% |
| 2022 Q4 | -6.07 Million AUD | 0.0% |
| 2022 Q2 | -5.13 Million AUD | 0.0% |
| 2022 FY | - AUD | -80.87% |
| 2021 Q2 | -2.22 Million AUD | 0.0% |
| 2021 Q4 | -3.96 Million AUD | 0.0% |
| 2021 FY | - AUD | -68.38% |
| 2020 Q4 | -2.23 Million AUD | 0.0% |
| 2020 FY | - AUD | -5.67% |
| 2020 Q2 | -1.44 Million AUD | 0.0% |
| 2019 FY | - AUD | 42.71% |
| 2019 Q4 | -1.44 Million AUD | 0.0% |
| 2019 Q2 | -1.89 Million AUD | 0.0% |
| 2018 Q2 | -3.37 Million AUD | 0.0% |
| 2018 Q4 | -2.7 Million AUD | 0.0% |
| 2018 FY | - AUD | -60.28% |
| 2017 Q2 | -2.01 Million AUD | 0.0% |
| 2017 FY | - AUD | -664.24% |
| 2017 Q4 | -1.92 Million AUD | 0.0% |
| 2016 Q2 | -31.95 Thousand AUD | 0.0% |
| 2016 FY | - AUD | -14470.11% |
| 2016 Q4 | 144.65 Thousand AUD | 0.0% |
| 2015 Q3 | - AUD | 0.0% |
| 2015 Q1 | - AUD | 0.0% |
| 2015 Q4 | 3453.00 AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 FY | - AUD | 21.54% |
| 2014 FY | - AUD | -4.47% |
| 2013 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AdAlta Limited | -5.3 Million AUD | -167.852% |
| Acrux Limited | -7.93 Million AUD | -79.087% |
| Actinogen Medical Limited | -12.92 Million AUD | -9.923% |
| AnteoTech Limited | -11.57 Million AUD | -22.75% |
| Argenica Therapeutics Limited | -1.89 Million AUD | -648.495% |
| Arovella Therapeutics Limited | -8.83 Million AUD | -60.796% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -875.062% |
| Alterity Therapeutics Limited | -19.57 Million AUD | 27.429% |
| Amplia Therapeutics Limited | -4.55 Million AUD | -211.505% |
| Avecho Biotechnology Limited | -3.24 Million AUD | -338.036% |
| Bio-Gene Technology Limited | -2.97 Million AUD | -377.426% |
| Biome Australia Limited | -1.57 Million AUD | -799.944% |
| Biotron Limited | -5.04 Million AUD | -181.81% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | -2.04% |
| BTC Health Limited | 1.05 Million AUD | 1445.925% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | -25.696% |
| CSL Limited | 4.73 Billion AUD | 100.3% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | 68.188% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 127.386% |
| Cynata Therapeutics Limited | -9.95 Million AUD | -42.745% |
| Dimerix Limited | -24.95 Million AUD | 43.092% |
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 236.894% |
| Hexima Limited | -995.54 Thousand AUD | -1326.696% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | -404.002% |
| Immuron Limited | -6.19 Million AUD | -129.369% |
| Immutep Limited | -42.87 Million AUD | 66.873% |
| Imugene Limited | -147.97 Million AUD | 90.402% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | -1871.484% |
| Memphasys Limited | -3.3 Million AUD | -329.401% |
| Nanollose Limited | -1.14 Million AUD | -1137.335% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 107.128% |
| Noxopharm Limited | -5.94 Million AUD | -138.893% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | -690.708% |
| Nyrada Inc. | -4.59 Million AUD | -209.024% |
| Orthocell Limited | -11.68 Million AUD | -21.593% |
| PharmAust Limited | -9.45 Million AUD | -50.273% |
| Patrys Limited | -3.49 Million AUD | -306.723% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | 77.993% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | -80.079% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -97.662% |
| PYC Therapeutics Limited | -38.11 Million AUD | 62.738% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | 68.699% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | 33.486% |
| Starpharma Holdings Limited | -12.57 Million AUD | -12.931% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 161.845% |
| Tissue Repair Ltd | -5.77 Million AUD | -145.946% |
| Zelira Therapeutics Limited | -36.44 Million AUD | 61.024% |